Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Brahmer, J.; Balmanoukian, A.; Goldberg, S.; Ou, S. H.; Blake-Haskins, A.; Karakunnel, J.; Stockman, P.; Rizvi, N.; Antonia, S. |
| Abstract Title: | Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung cancer (NSCLC) |
| Meeting Title: | 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 2 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2014 Nov 6-9 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2014-11-06 |
| Language: | English |
| DOI: | 10.1186/2051-1426-2-S3-P179 |
| PROVIDER: | manual |
| PMCID: | PMC4288573 |
| Notes: | Meeting Abstract: P179 |
